Jessica Jager-Amsellem

Angers, FR 
Angers, FR 

Overview

Jessica Jager-Amsellem practices practicing medicine in Angers, France.

Her clinical expertise encompasses Diabetic Hyperglycemic Hyperosmolar Syndrome, Obesity in Children, Noonan Syndrome, and RASopathies.

She is actively involved in clinical research, co-authoring 11 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Angers, 49000, France
Other Locations
Lille, France
Blois, 41000, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study With an Open-Label Extension Assessing the Efficacy, Safety, and Pharmacokinetics/Pharmacodynamics of Tirzepatide in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, or Basal Insulin, or Both
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study With an Open-Label Extension Assessing the Efficacy, Safety, and Pharmacokinetics/Pharmacodynamics of Tirzepatide in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, or Basal Insulin, or Both
Enrollment Status: Completed
Publish Date: September 26, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 3

11 Total Publications

RAS/MAPK pathway modulation with simvastatin in children with Noonan syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
RAS/MAPK pathway modulation with simvastatin in children with Noonan syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
Journal: EClinicalMedicine
Published: March 24, 2026

Frequently Asked Questions about Jessica Jager-Amsellem

Is Jessica Jager-Amsellem a top-rated expert for Diabetic Hyperglycemic Hyperosmolar Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Jessica Jager-Amsellem is classified as an Experienced expert for Diabetic Hyperglycemic Hyperosmolar Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jessica Jager-Amsellem participate in research or clinical trials?

Yes. Jessica Jager-Amsellem has published 11 articles and abstracts on conditions like Diabetic Hyperglycemic Hyperosmolar Syndrome. You can view a list of Jessica Jager-Amsellem's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Jager-Amsellem's expertise for a condition
ConditionClose
        View All 8 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile